THREE-PART PRICING TO REWARD PHARMACEUTICAL INNOVATION AND INCREASE ACCESS: CASE OF PCSK9 INHIBITORS
Authors
CHENG W
HLÁVKA Jakub
SNOWBERG Erik
VAN NUYS Karen
GOLDMAN Dana P.
Year of publication
2018
Type
Conference abstract
Citation
By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Settings